Thursday, May 23, 2013

• Johnson & Johnson Pharmaceuticals Segment Poised to Continue Driving Growth with More than 10 Potential New Product Filings by 2017PR Newswire( (Thu, May 23)

Tuesday, May 21, 2013

• Cordis Showcases Cardiovascular Innovations at EuroPCR 2013Business Wire( (Tue, May 21)

Monday, May 13, 2013

• Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety and Effectiveness of the THERMOCOOL® SMARTTOUCH™ CatheterBusiness Wire( (Mon, May 13)

Thursday, May 9, 2013

• First Patient Enrolled in reMARQable Clinical Study Evaluating the Safety and Efficacy of Multi-Electrode nMARQ™ Pulmonary Vein Isolation System™ in the Treatment of Paroxysmal Atrial FibrillationBusiness Wire( (Thu, May 9)

Wednesday, May 8, 2013

• Biosense Webster Showcases Cutting Edge Innovation and Leadership in AF Ablation at HRS Annual Scientific Sessions 2013Business Wire( (Wed, May 8)

Thursday, May 2, 2013

• Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)PR Newswire( (Thu, May 2)

Thursday, April 25, 2013

• Johnson & Johnson Announces Dividend Increase of 8.2%PR Newswire( (Thu, Apr 25)

Tuesday, April 23, 2013

• Johnson & Johnson to Host Pharmaceuticals Business ReviewPR Newswire( (Tue, Apr 23)

Thursday, April 18, 2013

• Johnson & Johnson Announces Sale of Elan American Depositary Shares to ElanPR Newswire( (Thu, Apr 18)

Tuesday, April 16, 2013

• Johnson & Johnson Reports 2013 First-Quarter Results:PR Newswire( (Tue, Apr 16)

Thursday, April 11, 2013

• Johnson & Johnson to Webcast Annual Meeting of ShareholdersPR Newswire( (Thu, Apr 11)

Tuesday, April 9, 2013

• Look And Feel Great This Spring, Despite Allergy SymptomsPR Newswire( (Tue, Apr 9)